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ABSTRACT
Introduction Health information is a prerequisite of 
informed decision- making. Criteria for development, 
content and presentation have recently been published 
in a corresponding guideline. Within a systematic 
search, 27 relevant checklists were identified, none 
of them, however, complying with the guideline or 
providing reasonably operationalised measurement 
items. Therefore, a draft of a checklist with 19 criteria 
was drafted. The current study aims at developing and 
validating this measure of quality.
Methods and analysis The validation design consists 
of five single studies to be conducted at the University of 
Halle- Wittenberg/Germany and Graz/Austria. (1) Achieving 
content validity through expert reviews of the first draft, 
(2) achieving feasibility using ‘think aloud’ in piloting with 
untrained users, (3) pretesting the instrument applied to 
health information materials without use of secondary 
sources: determining inter- rater reliability and criterion 
validity, (4) determining construct validity using information 
on proceedings and methods in the development 
process provided by the developers and (5) determining 
divergent validity in comparison with the Ensuring Quality 
Information for Patients (EQUIP) (expanded) Scale. The 
substudies will use varying samples of experts, students 
and developers and will apply the instrument to materials 
of various domains. Sample sizes will be adjusted to the 
particular research designs and questions. Analyses will 
employ qualitative methods, such as content analyses and 
discourse within the expert panel, and correlation- based 
methods both for determining inter- rater reliability and 
validity.
Ethics and dissemination The project is approved by 
the ethics committee of the Martin Luther University Halle- 
Wittenberg (approval number: 2019 115). Results will be 
published, and the instrument made accessible on public 
health platforms. It is meant to become a certification 
standard. MAPPinfo can be used as a screening instrument 
without training or secondary sources. Although developed 
in the German language, the instrument will be applicable 
also in other languages.
Trial registration number AsPredected22546; date of 
registration: 24 July 2019.
Protocol version July 2020.
INTRODUCTION
The study comprises the development and 
validation of an instrument that operation-
alises the ‘guideline evidence- based health 
information (EBHI)’,1 2 which has been 
developed in a cooperation project between 
the University of Hamburg, Health Science 
and Education and the German Network of 
Evidence- Based Medicine (DNEbM), section 
‘patient information and participation’.
The provision of science- based and easily 
understandable health information—
so- called EBHI—is called for both nationally 
and internationally.3 EBHI is a prerequisite 
for informed choice, assuming that those 
concerned have sufficient knowledge and are 
in line with individual preferences.4 Most citi-
zens want more information and in particular 
more reliable information as well as greater 
participation in the decision- making process.5 
In Germany, the patients’ right to EBHI is 
based on the Patient Rights Act and an ethical 
claim.6 7 In 2015, the German National Cancer 
Plan developed a ‘Roadmap—informed 
and shared decision- making till 2020’. The 
Strengths and limitations of this study
 ► The study is strong as it builds on a systematic 
search and evidence update.
 ► The study provides the first approach to measuring 
quality of health information using evidence- based 
criteria.
 ► The new instrument passes a sound multistep vali-
dation procedure.
 ► Quality assessment is limited to evidence- based cri-
teria, implying that potentially important aspects are 
not considered.
 ► The new instrument works like a quality screening 
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DNEbM’s section ‘patient information and participa-
tion’ published the second version of the ‘Good Practice 
Health Information’ in 2016, which refers to the need for 
standards.8
In Austria, the Health Target Number 3—to enhance 
health literacy in the population—refers to the need for 
‘facilitating access to objective, easily comprehensible 
information of assured quality’.9 The Austrian Target- 
Based Governance Agreement 2017–2021 at federal level 
was agreed for the years 2017–2021. Within the framework 
of this agreement, numerous measures have been agreed 
to improve health and strengthen health literacy, respec-
tively, for example, implementation of standards for good- 
quality health information.10 In 2018, the Austrian quality 
criteria for good health information were published by 
the Federal Ministry of Labor, Social Affairs, Health and 
Consumer Protection and the Austrian Health Literacy 
Alliance.9
Although the criteria for EBHI have been defined by 
national and international working groups for years with 
the aim of enabling informed decisions,11 12 the imple-
mentation into practice is currently not successful.13 14
The ‘guideline EBHI’1 is also an international novelty. 
Representatives from 22 institutions and associations 
as well as three patient representatives worked on 
developing the guideline, which in the long run shall 
contribute to ensuring the quality of health information 
and thus support informed decision- making by patients. 
In healthcare, guidelines are important tools for everyday 
care and can improve the quality of care if successfully 
implemented.15 In addition, training programmes are 
recommended to facilitate the implementation of clinical 
guidelines.16
The efficacy of the ‘guideline EBHI’ combined with a 
training programme is currently under evaluation in a 
randomised controlled trial.2 Compliance to the guide-
line will be determined by assessing the quality of newly 
developed health information material using the instru-
ment to be developed according to the present study 
protocol.
The current protocol describes the process of devel-
oping and validating MAPPinfo to assess the quality 
of health information as an outcome measure. Until 
now, there is no instrument available that is capable of 
assessing the quality of health information according 
to the guideline criteria. We carried out a systematic 
research for such instruments in the Pubmed, Psyndex 
and Psycinfo databases. Search terms are provided in 
box 1.
Among a total of 5544 matches, two independently 
working project members (JL, JK) identified a pool of 40 
potentially relevant instruments in a total of 256 publica-
tions. Measures focusing purely on readability or specific 
medical domains or published in other than English or 
German language were excluded. Table 1 outlines the 
characteristics of the 27 included instruments.
Based on the guideline’s quality concept,1 none of 
these was considered sufficiently suitable for registering 
the quality of health information. The following short-
comings have been identified:
 ► Incompleteness of the quality criteria.
 ► Inadequate or lacking operationalisation of individual 
criteria.
 ► Use of criteria not covered by the present state of 
knowledge (ethics or scientific evidence).
 ► Lack of validation.
Against this background, the development and vali-
dation of an assessment tool for health information are 
considered necessary.
Drafting the measuring instrument
Through discussion in the research group, an instrument 
has been drafted as a checklist that can be used without 
special training or secondary sources. The concept of 
quality, operationalised in the instrument, is not a new 
invention but corresponds to the criteria agreed on in the 
guideline. The draft includes criteria and items, a category 
structure, a corresponding simple manual and a measure-
ment concept. The instrument is called MAPPinfo.
Objective
In the current study, MAPPinfo is to be tested for its 
quality parameters. The validation steps planned here 
are intended in particular to examine the extent to 
which consistent quality assessments of independently 
working assessors are generated (reliability) and whether 
limiting the assessment to the immediately observable 
features permits a sufficiently accurate quality assessment 
(validity).
After its validation, MAPPinfo will be published in 
English and made available via the project page of the 
guideline in order to achieve the greatest possible trans-
parency for the quality concept and user- friendliness of 
quality evaluations. Depending on the results of the vali-
dation studies, additional assessment procedures will be 
developed to allow for more complete and comprehen-
sive assessments and evaluations where appropriate.
METHODS AND ANALYSIS
The development process consists of the following steps 
(hereafter called substudies):
Box 1 Search terms
Group 1: assessment (apprais* OR assess* OR measur* OR instrument* 
OR checklist OR rating OR rate OR scale* OR test*), Group 2: quality 
criteria (qualit* OR criteria OR standard*), Group 3: health information 
(“Patient Education Handout”(Publication Type) OR “Consumer Health 
Information”(Mesh) OR “Pamphlets”(Mesh) OR “health information” 
OR “patient information” OR “decision aid” OR “decision aids” OR 
“information material” OR “information materials” OR ((patient OR 
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Expert review/content validity
The draft of the MAPPinfo instrument will be reviewed 
by relevant experts not previously involved in test devel-
opment. Comments and objections will be reexamined 
during the discussion and used as a basis for an initial 
revision.
Pilot testing (trial application)/feasibility study
Members of the target group will then carry out a pilot 
test with MAPPinfo. This process will be accompanied by 
a qualitative study, which uses interviews to collect data 
about the usability and comprehensibility. The findings 
will be included in a new revision.
Pretest/determining the (inter-rater) reliability
MAPPinfo will then be used extensively by the user target 
group to assess health information from a test sample. 
The aim of this study is the determination of inter- rater 
reliability values under field conditions. In case inter- rater 
agreement is not sufficient, substudies 2 and 3 have to be 
repeated until the current version has proven reliable.
Comparison with self-declarations by information developers/
construct validity
In this substudy, the assessment quality of MAPPinfo 
will be compared with the judgement of an expert that 
is based on more extensive background information 
provided by the developers by means of self- declaration. 
This method provides, on the one hand, a quantitative 
indicator for estimating the construct validity. On the 
other hand, the construct validity can also be described 
qualitatively (correlation design/survey).
Comparison with alternative instrument/divergent validity
In this substudy, MAPPinfo evaluations will be compared 
with quality evaluations ascertained with another estab-
lished quality measuring instrument. Discriminative 
validity would be meaningful to determine the relation to 
several existing instruments. For the first attempt, EQIP 
(EQIP 36 items17) will be used, which is an instrument 
that addresses not only some evidence- based criteria 
but also other reasonable criteria (correlation design/
survey).
Samples
The validation of the new assessment tool over five 
substudies will involve four different samples, HI test 
samples (materials), experts of EBHI, representatives of 
the targeted user groups and developers.
For validation purposes, the use of several domains for 
homogenous health information samples seems reason-
able. Health information samples in the domain of contra-
ception, gonarthrosis and endometriosis will be generated 
by systematic searches. HI for substudy 4, however, will 
be selected from mixed domains striving to maximise 
heterogeneity in this validation step. A screening process 
is employed to identify the health information material 
suitable for MAPPinfo assessment among a bigger pool of 
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1. The information has patients or medically non- 
professional people as its target group.
2. As a minimum precondition of choice, the informa-
tion deals with different management alternatives.
3. The part of the source relevant for the assessment is 
identifiable: for example, chapter, excerpt or subpage.
In the substudies, the targeted user group will be repre-
sented by students of Health and Nursing Science at the 
Martin Luther University Halle- Wittenberg, who have not 
been directly involved in the present implementation 
project of the guideline EBHI. These students will pilot 
and pretest the assessments of the given HI examples.
Experts of EBHI will be involved at several stages in 
the project. First, researchers in the field not previously 
involved in the development will be recruited from the 
environment of the DNEbM network and asked to review 
the draft as a content validation. In addition, members 
of the project group will act as the reference standard in 
several substudies and will also appraise additional infor-
mation collected from HI developers (substudy 4). Those 
experts will always work as a panel.
Substudy 4 requires recruitment of developers as 
an additional information source for a more compre-
hensive appraisal of HI. Developers will be strategically 
recruited from six distinct developer groups: health insur-
ances, practitioners, patient organisations, commercial 
providers, developers from the state sector and hospitals.
Strategies of recruitment and suitable size of the respec-
tive samples vary between the substudies. Table 2 gives 
an overview of the sampling within the entire validation 
project.
Data collection
Subsequent substudies in this validation plan will not be 
initiated until the respective previous steps have achieved 
their aim. New revisions will be elaborated and the 
conduct of each validation (substudy) will be repeated 
until proof of validity has been provided to a satisfying 
extent. The history of the revisions will be documented 
in a separate log including causes of revisions and corre-
sponding discourse within the research panel.
Description of the draft: MAPPinfo
MAPPinfo has been developed on the basis of valid quality 
criteria, the good practice guidelines for health informa-
tion,18 the criteria of evidence- based patient informa-
tion11 and the ‘guideline EBHI’.1 However, the selection 
and distribution of items as well as decisions about the 
particular operationalisation and answering formats have 
been inspired by a fused total pool of items from all instru-
ments existing so far. In particular, items were defined 
based on guideline recommendations. The total pool of 
items from the review was then screened for additional 
evidence- based criteria not covered by the guideline. 
Moreover, operationalisations from different versions of 
assessing the same criterion were compared and discussed 
before a new item was constructed. MAPPinfo is designed 
to assess materials intended to inform medical decisions. 
Medical decisions are defined as decisions on preven-
tion and health promotion, early detection, diagnostics, 
treatment, palliation, rehabilitation, nursing, after- care 
and coping with diseases. The manual distinguishes itself 
from other types of health information, by explaining, 
for example, the implementation of a specific measure, 
or informing about the health system or giving general 
health tips.
The instrument is intended for evaluating those quality 
criteria that can be observed in the respective health 
information or directly linked sources. This means that, 
if required, transparency can be shown by means of a 
methods’ report or documentation on health infor-
mation. Quality criteria in the categories definitions, 
transparency, content and presentation are regarded as 
verifiable. However, with MAPPinfo, it will not be possible 
to check the correctness of the content of the informa-
tion and the appropriateness of the methods used in the 
development process.
MAPPinfo is intended to provide a structure to the 
assessment of compliance with guideline recommenda-
tions, as justified either by the ethical guidelines or by the 
current state of research. Thus, the criteria listed in the 
taxonomy are considered essential but not sufficient to 
promote an informed decision. Many of the characteris-
tics likely to be important for the quality of health infor-
mation are not part of the examination, as a particular 
Table 2 Sampling overview for the entire validation project
Substudy






review of the 
draft
– Convenient




5 HI/ contraceptives Three raters: health 
scientists5 HI/ gonarthrosis
3. Pretest Random Convenient
25 HI/contraceptives Five raters: students 
of health sciences and 






50 HI 50 developers of HI, 





Full survey (x) Convenient
Endometriosis HI 2×2 raters: health 
scientists
The table presents two types of samples: materials and assessors, 
the people either reviewing or applying the instrument.
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recommendation is not yet justifiable. On the other hand, 
non- compliance with any of the criteria in MAPPinfo is 
already seen as a barrier to informed decision- making.
MAPPinfo is conceptualised so that the instrument 
can be used by people with basic knowledge of evidence- 
based medicine but without any training as an evaluator.
Ad 1: expert review/content validity
Two independently working experts in the field of EBHI 
will review the draft with regards to content validity of 
the particular operationalisation of the criteria. Written 
comments will be collected and in addition interviews will 
be used to secure understanding. A revision of the instru-
ment will be created after discourse in the research panel.
Ad 2: pilot testing (trial application)/feasibility study
The MAPPinfo will then pass a number of consecutive test 
applications with three different raters from the target 
group and two different kinds of health information. The 
test applications will be accompanied by participating 
observation (by JK) using the ‘think aloud’ method. The 
interviewer will encourage the participants repeatedly 
to express any ideas, doubts or concerns. If participants 
indicate a problem, the interviewer will explore its nature 
and importance and invite the participants to discuss 
possible solutions. All the problems will be documented 
for later analysis in the research group. Findings from this 
pilot testing will be fed continuously into the revision of 
the instrument and new pilots will be conducted based 
on a revised version. This kind of investigation will be 
continued until saturation with regards to the feasibility 
and comprehension of the MAPPinfo is reached.
Ad 3: pretest/determining the (inter-rater) reliability
The proven feasible version of the new instrument will 
then be exposed to a pretest, comprising appraisal of 
a selection of 50 health information websites by five 
members of the target group and additionally by an 
expert panel (AS, JK) representing a reference standard. 
Each piece of information will be independently rated two 
times using the MAPPinfo. The expert panel will make a 
general judgement on a 0–10- point Likert- type scale. All 
the raters will be blinded to each other’s judgements.
Ad 4: comparison with self-declarations by information developer/
construct validity
In this step, additional information relevant to quality of 
the health information websites will be collected from 
the developers. For this purpose, a questionnaire will be 
created in an online format (MAPPinfo- Develop), which 
developers of the aforementioned information materials 
are asked to complete. In particular, the questionnaire 
shall provide clues for extended quality appraisal, which 
beyond the categories definitions, transparency, content 
and presentation also leans on the categories develop-
ment methods and development process. The latter are 
not directly observable within the health information but 
are to a far extent accessible based on the developers’ 
self- declaration. The questionnaire will use free text 
answering formats and will be piloted before the initia-
tion of the survey.
The following particular topics will be contained in the 
self- declaration questionnaire. The specific formulation 
and design of the items is subject of the respective study 
step 4:
 ► Justification of the search strategies for the evidence 
update.
 ► Proceedings for inclusion of studies.
 ► Appraisal of the existing evidence.
 ► Exhaustiveness of the set of patient- relevant outcome 
parameters.
 ► Evaluation (stage of evaluation, methods used at 
different stages of piloting, where population was 
studied, results of the evaluation steps, conclusions 
drawn from results of evaluation and revision done…).
Developers will be identified via HI published in the 
internet and invited to fill in the online questionnaire 
focusing on one particular HI they have developed. 
There will be no need to provide personal data, whereby 
consent is given to proceed as described.
The health information examples chosen by the devel-
opers will be rated with the MAPPinfo checklist by health 
students. In addition, they will pass an expert appraisal 
by using the collected free text answers with regards 
to an additional set of quality criteria. The experts will 
be blinded towards the results of the checklist, and the 
students will be blinded to the experts’ appraisal. The 
experts’ appraisal will be transformed into a quantitative 
supplemental score (MAPPinfo- extended) to be added to 
the corresponding MAPPinfo score.
Ad 5: comparison with alternative instrument/divergent validity
Provided that the inter- rater reliability at step 3 was 
proven satisfactory, a new set of information materials will 
be assessed using MAPPinfo and EQIP36.17 Ratings with 
the two different instruments will be done independently 
by different raters. Both rater groups will be drawn from 
the same population (health sciences studies) and need 
comparable levels of preknowledge.
Analyses
The substudies 1 and 2 will use discourse within the 
research group as qualitative methods of problem analysis 
and management. Each documented problem needs to 
be fully understood and appraised with regards to the risk 
this problem includes. Then an inductive process will be 
initiated where solutions are drafted and respective risks 
are appraised before a decision is made about whether to 
keep the original version or to refine the instrument in 
a specific manner. Decisions based on discourse in this 
study will be unanimous.
Substudy 3 will calculate T- coefficients and percentage 
agreement between two data columns representing pair-
wise judgements of each item.19 T has been chosen as 
a suitable coefficient for ordinal scaled scores, while—
contrary to Cohen’s kappa—expected frequencies are 
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marginal distribution. This decision is based on the 
assumption that a rater using the MAPPinfo should in 
his or her judgements not be influenced by the specific 
distribution in the test sample. Four items address both 
the quality of content and of presentation and will enter 
the analysis with a double weight. T- coefficients will be 
considered as moderate between 0.40 and 0.60, as strong 
higher than 0.60 and as excellent higher than 0.80.20 
Spearman correlation coefficients will be calculated to 
compare expert panel ratings on a 0–10 scale with the 
MAPPinfo mean score. This correlation is an estimator 
for criterion validity.
Substudy 4 will calculate Spearman correlation coef-
ficients between MAPPinfo mean scores and MAPPinfo 
plus MAPPinfo- extended mean scores. The resulting 
correlation will be an estimate of the MAPPinfo check-
list’s construct validity. In a second step, discrepancies 
between judgements based on MAPPinfo only or with the 
expansion will be analysed on a qualitative level. The aim 
is to identify eventual constellations where judgement 
without insight into the development process might be of 
low validity or even misleading.
Substudy 5 will calculate Spearman correlation coeffi-
cients between quality appraisal made by using MAPPinfo 
and the EQIP36. Therefore, the mean scores of the two 
instruments will be used. The correlation is expected to 
achieve significance level and will be used as an estimate 
for a divergent validity.
Patient and public involvement
No patients are involved.
DISCUSSION
We expect the new instrument to prove capable of 
checking criteria in the categories definitions, transpar-
ency, completeness of contents and appropriate presen-
tation. The instrument can be used without training and 
will be applicable for information about all kinds of health 
problems, if more than one option exists. The quality of 
the instrument will be described in terms of its psycho-
metric properties. There are, however, a couple of limita-
tions and barriers. First of all, we have to bear in mind 
that not all features of health information will be tested, 
and therefore recommendations can be provided only 
for some of them. Moreover, MAPPinfo will only check a 
selection of these evidence- based criteria, omitting those 
not appraisable without access to background materials 
and procedures. MAPPinfo will therefore be acting on 
the level of a screening instrument. We will provide data 
to quantify the quality of the proxy with regards to an 
in- depth review of health information. The instrument 
can be considered suboptimal with regards to some of the 
recommendations from the classical test theory. Opera-
tionalising a rigorous ethical approach, all the items are 
constructed with low item difficulty and mostly dichoto-
mously. Although a more graduated assessment format 
and higher difficulty would make it easier to generate 
normally distributed data on information quality, this 
distribution would not reflect the current reality in the 
field of health information from the users’ point of view.
To summarise, the new instrument, MAPPinfo is 
urgently needed. The concept of quality is thoroughly 
anchored in the synthesis of the best available evidence. 
The validation studies will provide information about the 
reliability, accuracy and validity of the checklist.
ETHICS AND DISSEMINATION
The protocol has been approved by the ethics committee 
of the Martin Luther University Halle- Wittenberg 
(approval number: 2019 115) and the Ethical Princi-
ples for Medical Research Involving Human Subjects 
(World Medical Association Declaration of Helsinki) will 
be respected in this project.21 All the participants will 
provide informed consent.
The new measure is intended to become a certifica-
tion standard for public health information in Germany. 
Operationalisation of criteria of evidence- based HI 
has repeatedly been demanded by the DNEbM. The 
results will immediately be published in open access, 
peer- reviewed journals and translations of the checklist 
provided in the Norwegian and English languages. In 
addition, MAPPinfo will be available, for example, on the 
websites of the DNEbM and the guideline EBHI.1 The 
criteria assessed by MAPPinfo are applicable regardless 
of language, country or health system. However, the use 
of the instrument in other languages will require some 
additional validation works.
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